Understanding OUR Cytokine-Based Immunotherapy Candidates Our Commitment extends to advancing a robust portfolio of programs geared toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where procedure options remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/krakens-bid-for-deribit-still-on-the-table-as-copyright-shows-interest/